Health

  • August 18, 2026

    At DC Circ., Pharma's Latest Pricing Loss Has Silver Linings

    The pharmaceutical industry's far-flung crusade against Medicare's new negotiation powers suffered a fresh setback Tuesday as the D.C. Circuit joined sister circuits in upholding the landmark pricing program, but the defeat contained consolation prizes that will fuel further litigation.

  • August 18, 2026

    Ex-NFL Player Sues Disability Benefits Plan Over Denial

    A former National Football League player who reportedly suffered brain injuries from nearly two decades of playing the sport hit the league's disability benefit plan with a lawsuit Tuesday, telling a Maryland federal judge that the plan wrongfully denied his application for total and permanent disability benefits despite his own doctor's diagnosis.

  • August 18, 2026

    DC Circ. Revives Part Of Fight Over Braille-Free Drug Label

    The D.C. Circuit on Tuesday partially vacated a lower court judgment that had upheld the U.S. Food and Drug Administration's approval of a label without braille for Teva Pharmaceuticals' generic version of a drug often prescribed to blind people.

  • August 18, 2026

    Ambulance Co. Says Insurers Failed To Settle Crash Claims

    A Pennsylvania ambulance service alleged in state court that its insurers refused to consider a settlement offer within its policy limits to resolve claims stemming from a fatal crash, exposing the company to a higher judgment after the crash victim's estate added punitive damages to the underlying case.

  • August 18, 2026

    Harvard To Pay $53M Over Medical School Morgue Thefts

    Harvard University has agreed to pay $53 million to settle more than a dozen consolidated lawsuits over the theft of body parts from its medical school morgue by a former manager, lawyers for the plaintiffs said Tuesday.

  • August 18, 2026

    Bot Errors Doom Expert's Credibility In Tainted-Supplement Suit

    A Washington federal judge Tuesday disposed of a U.S. Army nurse's lawsuit claiming supplement maker Thesis Nootropics sold products tainted with amphetamines, concluding that a key expert destroyed his credibility by submitting a report containing bot-generated false citations — much like errors for which the plaintiffs' counsel was recently sanctioned.

  • August 18, 2026

    Mich. Fights Atty Fee Demand in Newborn Blood Spot Lawsuit

    The state of Michigan told a federal judge on Tuesday that the $372,400 in legal fees requested by plaintiffs in a newborn blood spot lawsuit is "excessive" and that an award should be either delayed or significantly lowered.

  • August 18, 2026

    DEA Blasts Marijuana Foes' Objections To Rescheduling

    The U.S. Drug Enforcement Administration on Monday told an administrative law judge that federal restrictions should be loosened on marijuana and that opponents of cannabis reform brought a meritless challenge to health regulators' assessment of the drug's medical use.

  • August 18, 2026

    Orrick, Kirkland Steer Weave's $650M Take-Private

    Patient engagement platform and payment services company Weave Communications Inc., led by Orrick Herrington & Sutcliffe LLP, on Tuesday revealed it will become a private company after it was acquired by Kirkland & Ellis LLP-advised private equity shop Francisco Partners in a $650 million deal.

  • August 18, 2026

    Troutman Sidelined Associate After Heart Attack, Suit Says

    Troutman Pepper Locke LLP derailed an associate's career because he took medical leave to recover from a heart attack and spoke up about senior attorneys' fraudulent billing practices, according to a lawsuit filed Tuesday in New Jersey federal court.

  • August 18, 2026

    BioMarin Buying Alesta Therapeutics For Up To $490M

    Jones Day-advised BioMarin Pharmaceutical Inc. said Tuesday it has agreed to acquire Alesta Therapeutics for $275 million upfront and up to another $215 million tied to the development and regulatory progress of Alesta's lead drug candidate.

  • August 18, 2026

    11th Circ. Affirms Kickback Convictions For Pain Doc, Salesman

    The Eleventh Circuit on Tuesday affirmed the conviction and sentences of a Florida pain doctor and a salesman found guilty of participating in a kickback conspiracy for prescribing a fentanyl spray, ruling prosecutors had "overwhelming" evidence the men knowingly participated in "sham" drug promotion events.

  • August 18, 2026

    Aetna Says It Doesn't Use Repricing Tools In Antitrust Case

    Aetna Inc. urged a Massachusetts federal court to toss it from an antitrust case accusing insurance companies of using repricing tools to reduce reimbursements paid to healthcare providers, arguing that a subsidiary, not Aetna, used the tools at issue.

  • August 18, 2026

    Infant Formula MDL Judge Laments Ongoing 'Trial-By-Video'

    The Illinois federal judge handling multidistrict litigation claiming Mead Johnson or Abbott Laboratories infant formula led to a severe gut illness in premature babies deemed it "disappointing" that testimony in an ongoing bellwether trial largely consists of video depositions, warning she won't conduct another unless most witnesses will take the stand in Chicago.

  • August 18, 2026

    NC Doc Gets Prison For Opioid Recovery Prescription Scheme

    A federal judge has sentenced a North Carolina doctor to half a year in prison for letting administrative staff at a nonprofit where he worked as medical director use his credentials to prescribe the opioid use disorder medication buprenorphine to thousands of patients.

  • August 18, 2026

    Mich. Panel Revives $900K Hyperbaric Chamber Coverage Suit

    A Michigan appellate court panel on Monday revived Corewell Health's suit seeking recovery of nearly $900,000 from State Farm Insurance for hyperbaric oxygen therapy that was provided to a child who suffered a traumatic brain injury after he was struck by a vehicle while riding his bike.

  • August 18, 2026

    Medical Device Exec Cashed In On Bad Quarter, Feds Charge

    A former Treace Medical Concepts executive was arrested on insider trading charges Tuesday, after New York federal prosecutors said he exploited secret warnings about the Florida medical device company's sales and turned a $37,000 profit betting its stock would fall.

  • August 18, 2026

    LA Pot Partnership Deal Void, Calif. Appeals Court Says

    A California state appeals court has affirmed a lower court's determination that a partnership agreement tied to a group of medical marijuana dispensaries could not be enforced because it called for operations that violated a Los Angeles city ordinance.

  • August 18, 2026

    Marriott Gets Trim Of Worker's Tobacco Health Fee Suit

    A Maryland federal judge on Tuesday refused to completely toss a Marriott worker's proposed class action alleging the hotel giant's $15 weekly health fee on employees who use tobacco violated federal benefits law, but trimmed the dispute of some claims as insufficiently backed up. 

  • August 18, 2026

    Rising Star: Covington's Krysten Rosen Moller

    Covington & Burling LLP partner Krysten Rosen Moller's successes include helping secure a favorable resolution for a healthcare provider facing allegations of sprawling False Claim Act violations, and helping defeat a multibillion-dollar FCA whistleblower suit against a UnitedHealth subsidiary in front of the U.S. Supreme Court — earning her a spot among healthcare law practitioners under 40 honored by Law360 as Rising Stars.

  • August 18, 2026

    DLA Piper Taps Weil Partner As New York PE Co-Lead

    DLA Piper has announced it hired a Weil Gotshal & Manges LLP partner to co-lead its private equity practice in New York.

  • August 18, 2026

    Barnes & Thornburg Picks Up 12 K&L Gates Healthcare Attys

    Barnes & Thornburg LLP announced Tuesday that it has brought on a 12-lawyer healthcare team from K&L Gates, including that firm's two former practice group leaders.

  • August 18, 2026

    ​​​​​​​Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week tackled disputes involving multibillion-dollar mergers, corporate oversight, founder control, SPAC litigation, commercial contracts and attorney fees.

  • August 17, 2026

    Albertsons Judge Hears $44B Opioid Abatement Plan In Wash.

    Addressing harm caused by prescription opioid abuse in Washington would cost nearly $44.4 billion, an expert testified Monday during a bench trial in the state's case accusing Albertsons and its Safeway subsidiary of exacerbating Washington's overdose crisis by failing to curb the flow of controlled substances.

  • August 17, 2026

    COVID Test-Maker Inks $6.5M Investor Deal Over Sales Slump

    Co-Diagnostics Inc. has agreed to pay $6.5 million to settle an investor lawsuit accusing it of overstating the demand for its COVID-19 testing kits two years after the pandemic began.

Expert Analysis

  • How FCA, FCPA Risks Are Shifting As Feds Pull Back

    Author Photo

    As the federal government continues its retreat from white collar enforcement, companies should expect False Claims Act risk to grow through private whistleblower suits and Foreign Corrupt Practices Act scrutiny to shift toward foreign prosecutors, requiring more adaptability as accountability becomes less centralized, says Temidayo Aganga-Williams at Selendy Gay.

  • Trump Admin's Agency Records Purge Tests Judicial Notice

    Author Photo

    While courts commonly take judicial notice of data in government websites and reports, the Trump administration's recent modification or wholesale deletion of these sources means that litigants must look elsewhere to support trial admission of this information, says Jon Gryskiewicz at Lewis Baach.

  • Series

    Cow Horse Makes Me A Better Lawyer

    Author Photo

    Moving an unwilling 800-pound cow while riding a horse at high speed is exhilarating, a little unhinged and, at least for me, a surprisingly effective training ground for litigation — both demand focus, preparation over rigid planning and the willingness to act despite fear, says Ashley Zitrin at Glenn Agre.

  • PowerSchool Data Breach Ruling Underscores PE Liability

    Author Photo

    The recent California federal court decision in PowerSchool, where Bain Capital was unable to dismiss claims relating to a data breach based in part on Bain's preinvestment activities, is an important addition to the line of cases addressing investor liability for acts of a portfolio company, says Mark Kelley at MoloLamken.

  • What Prop 65 Listings For Welding Fumes, Drugs Mean For Cos.

    Author Photo

    With California poised to add welding chemicals and three medications to its list of known carcinogens under Proposition 65, businesses must assess risks from nontraditional pharmaceutical dispensing, occupational and environmental exposures to welding operations, and downstream exposures from the manufacture of both types of substances, says Gregory Berlin at Alston & Bird.

  • West Coast Health Cos. Must Brace For Federal Enforcement

    Author Photo

    In light of the U.S. Department of Justice's newly established West Coast strike force targeting healthcare fraud across Northern California, Arizona and Nevada, health organizations will need to prioritize knowledge, vigilance and operational discipline to reduce exposure from potentially parallel criminal and civil investigations, says Michael Beckwith at Dickinson Wright.

  • High Court's Hikma Decision Reshapes 'Skinny Label' Suits

    Author Photo

    The U.S. Supreme Court's decision in Hikma v. Amarin marks a significant victory for generic drug manufacturers, but rather than putting an end to so-called skinny label inducement claims, it narrows and refocuses them, say attorneys at Sterne Kessler.

  • Checking For AI Errors Is Now A Two-Way Street

    Author Photo

    A handful of recent federal and state cases demonstrate the importance of checking for errors generated by artificial intelligence not only in your own court submissions, but also your opponent's, as well as when catching opposing counsel's AI mistakes could result in an award for attorney fees, says Tamara Barago at Hollingsworth.

  • Green Card Memo Warps Long-Standing Adjustment Process

    Author Photo

    A recent policy memorandum that treats a nonimmigrant visa holder’s decision to seek adjustment of status in the U.S., rather than at a U.S. consulate, as an adverse factor reinterprets existing discretionary frameworks, compounds risks for applicants required to apply abroad and changes practitioner approaches to application preparation, says attorney Jack Jrada.

  • Series

    The Biz Court Digest: Shoring Up Corporate Law In Maryland

    Author Photo

    Launched more than 20 years ago to improve complex corporate adjudication, Maryland's Business and Technology Case Management Program has been a solid success in some areas, but there always is room for improvement, says Bill Krulak at Miles & Stockbridge.

  • Series

    Competing At Poker Makes Me A Better Lawyer

    Author Photo

    Playing poker in male-dominated rooms taught me to treat skepticism as background noise when my opponents seem to underestimate me, to apply pressure when it matters and to adapt without losing strategic discipline — skills that are all indispensable in restructuring and insolvency matters, says Alexis Gambale at Pashman Stein.

  • 5 Things Associates Must Ask About Their Firm's Merger Plan

    Author Photo

    The associates who navigate law firm mergers best ask the right questions early, such as inquiring about partners' plans, to assess how the merger could affect their workflow and career path, says Jackie Bokser-LeFebvre at Major Lindsey.

  • Brain Computer Interfaces Boot Up Multipronged Legal Issues

    Author Photo

    As neurotechnology companies begin to conduct human clinical trials for brain computer interfaces, attorneys should prepare for legal ramifications across a broad range of practice areas, including intellectual property, privacy and product liability, say attorneys at ArentFox Schiff.

  • Turning To The Courts When PBM Reform Falls Short

    Author Photo

    The effectiveness of state laws intended to regulate pharmacy benefit managers remains uncertain, but litigation — utilizing tried-and-true theories like breach of contract and fair dealing — offers another mechanism through which stakeholders may seek relief from PBMs, say attorneys at Reed Smith.

  • 2 'Rocket Dockets' And The Rules That Propel Them

    Author Photo

    The fastest civil trial courts in the country are currently in the Eastern District of Virginia and the Southern District of Florida, and their chief judges provide insights into the court rules that keep them ahead, says Robert Tata at Hunton.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.